Clinical trial
Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene…
NCT00336791 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00336791 |
|---|---|
| Title | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer |
| Official title | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression Profile-Based Test to Select Patients for Preoperative Taxane/Anthracycline Chemotherapy for Stage I-III Breast Cancer |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Breast Cancer Research Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | 5-Fluorouracil, Cyclophosphamide, Doxorubicin, Paclitaxel, Epirubicin |
| Enrollment | 273 |
| Start date | Sep 1, 2003 |
| Primary completion | Aug 1, 2007 |
| Completion | Sep 1, 2010 |
| First posted | Jun 14, 2006 |
| Last update posted | Feb 14, 2012 |
| Countries | Mexico, Peru, Spain, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: